Who sells to McKesson
12 listed companies name McKesson as a customer behind 10% or more of their revenue, led by Rigel Pharmaceuticals at 42%.
Each share is of the supplier’s own revenue: how much of its business McKesson is. McKesson's own customers and margins
Suppliers that name McKesson
McKesson as a share of each supplier's revenue, largest first.
| Supplier | Of its revenue | Annual report |
|---|---|---|
| RIGLRigel Pharmaceuticals | 42% | FY2025 10-K |
| BMYBristol Myers Squibb | 36% | FY2025 10-K |
| ALKSAlkermes | 31% | FY2025 10-K |
| PCRXPacira BioSciences | 31% | FY2025 10-K |
| PFEPfizer | 25% | FY2025 10-K |
| AMPHAmphastar Pharmaceuticals | 24% | FY2025 10-K |
| EXELExelixis | 19% | FY2025 10-K |
| ARDXArdelyx | 18% | FY2025 10-K |
| ONCBeOne Medicines | 18% | FY2025 10-K |
| BHCBausch Health Companies | 16% | FY2025 10-K |
| BLCOBausch + Lomb | 10% | FY2025 10-K |
| JAZZJazz Pharmaceuticals | 10% | FY2025 10-K |
A US company has to name every customer behind 10% or more of its revenue in its annual report. This page lists the listed companies whose latest 10-K, 20-F or 40-F names McKesson that way. Suppliers below the 10% line, private suppliers and suppliers that keep the customer anonymous do not appear. Who depends on whom has the same disclosures across every company.